Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 23, 2021
Grant Date -
Jan 11, 2018
app pub date -
Jul 7, 2017
filing date -
Jul 8, 2016
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed herein are assays and methods for the identification of premalignant lesions, as well as methods of determining the likelihood that such premalignant lesions will progress to lung cancer. Also disclosed are methods and assays that are useful for monitoring the progression of premalignant lesions to lung cancer. The assays and methods disclosed herein provide minimally invasive means of accurately detecting and monitoring the presence or absence of premalignant lesions, thus providing novel insights into the earliest stages of lung cancer and facilitating early detection and early intervention.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully